Browsing byAuthorDureja, H

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 115  next >
Issue DateTitleAuthor(s)
2024-0318-β-Glycyrrhetinic acid encapsulated PLGA nanoparticles attenuate lung cancer proliferation and migrationPaudel, KR; Mohamad, MSB; De Rubis, G; Reyes, R-J; Panth, N; Dureja, H; Gupta, G; Singh, SK; Madheswaran, T; Collet, T; Hansbro, PM; Dua, K; Chellappan, DK
2023-12A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapiesThapa, R; Gupta, G; Bhat, AA; Almalki, WH; Alzarea, SI; Kazmi, I; Saleem, S; Khan, R; Altwaijry, N; Dureja, H; Singh, SK; Dua, K
2021-02-04Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancerGupta, G; Kazmi, I; Al-Abbasi, FA; Singh, Y; S, R; Rani, S; Mishra, A; Prasher, P; Jha, NK; Thangavelu, L; Dureja, H; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K
2022-01-01Advanced drug delivery system in the treatment of hyperglycemia and hypoglycemiaArora, V; Kabra, A; Sharma, RB; Dureja, H; Dua, K
2020-11Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesisMehta, M; Prasher, P; Sharma, M; Shastri, MD; Khurana, N; Vyas, M; Dureja, H; Gupta, G; Anand, K; Satija, S; Chellappan, DK; Dua, K
2023-11-04Advanced Drug Delivery Systems for Colonic DisordersDureja, H; Loebenberg, R; Singh, SK; Dhanasekaran, M; Dua, K
2022-01-01Advanced drug delivery systems for targeting obesityGulati, N; Dua, K; Dureja, H
2022-01-01Advanced drug delivery systems targeting metabolic disorders: erythropoietic protoporphyriaVerma, N; Thapa, K; Kanojia, N; Dureja, H; Dua, K
-Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseasesGulati, N; Chellappan, DK; MacLoughlin, R; Gupta, G; Singh, SK; Oliver, BG; Dua, K; Dureja, H
-Advances in pulmonary drug delivery targeting microbial biofilms in respiratory diseasesSharma, A; Kumar, D; Dahiya, K; Hawthorne, S; Jha, SK; Jha, NK; Nand, P; Girgis, S; Raj, S; Srivastava, R; Goswami, VK; Gregoriou, Y; El-Zahaby, SA; Ojha, S; Dureja, H; Gupta, G; Singh, S; Chellappan, DK; Dua, K
2020-01Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α.Aljabali, AAA; Bakshi, HA; Hakkim, FL; Haggag, YA; Al-Batanyeh, KM; Al Zoubi, MS; Al-Trad, B; Nasef, MM; Satija, S; Mehta, M; Pabreja, K; Mishra, V; Khan, M; Abobaker, S; Azzouz, IM; Dureja, H; Pabari, RM; Dardouri, AAK; Kesharwani, P; Gupta, G; Dhar Shukla, S; Prasher, P; Charbe, NB; Negi, P; Kapoor, DN; Chellappan, DK; Webba da Silva, M; Thompson, P; Dua, K; McCarron, P; Tambuwala, MM
2021-02-24An overview of vaccine development for COVID-19Shahcheraghi, SH; Ayatollahi, J; Aljabali, AA; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Katari, NK; Mehta, M; Satija, S; Dureja, H; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Gupta, G; Dua, K; Lotfi, M; Bakshi, HA; Tambuwala, MM
2020-11-29Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro.Wadhwa, R; Paudel, KR; Chin, LH; Hon, CM; Madheswaran, T; Gupta, G; Panneerselvam, J; Lakshmi, T; Singh, SK; Gulati, M; Dureja, H; Hsu, A; Mehta, M; Anand, K; Devkota, HP; Chellian, J; Chellappan, DK; Hansbro, PM; Dua, K
2020-10-30Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549.Solanki, N; Mehta, M; Chellappan, DK; Gupta, G; Hansbro, NG; Tambuwala, MM; Aa Aljabali, A; Paudel, KR; Liu, G; Satija, S; Hansbro, PM; Dua, K; Dureja, H
2022-01-28Biological databases and tools for neurological disorders.Usman, MB; Ojha, S; Jha, SK; Chellappan, DK; Gupta, G; Singh, SK; Dua, K; Roychoudhury, S; Kumar, N; Khan, FA; Dureja, H; Upadhye, V; Zacconi, F; Prasanna, P; Kesari, KK; Ashraf, GM; Alexiou, A; Jha, NK
2022-06-13Biomedical applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches.Kaur, J; Gulati, M; Zacconi, F; Dureja, H; Loebenberg, R; Ansari, MS; AlOmeir, O; Alam, A; Chellappan, DK; Gupta, G; Jha, NK; Pinto, TDJA; Morris, A; Choonara, YE; Adams, J; Dua, K; Singh, SK
2021-06-23Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applicationsAnand, K; Chandrasekaran, B; Gupta, G; Dureja, H; Singh, SK; Gulati, M; Chellappan, DK; Balasubramanian, B; Femeela, I; Armugam, VA; Dua, K
2024Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases.Solanki, N; Gupta, G; Chellappan, DK; Singh, SK; Gulati, M; Paudel, KR; Hansbro, PM; Dua, K; Bhan, S; Saini, M; Dureja, H
2021-07-01Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19Jeyaraman, M; Muthu, S; Bapat, A; Jain, R; ES, S; Gulati, A; Channaiah Anudeep, T; Dilip, SJ; Jha, NK; Kumar, D; Kesari, KK; Ojha, S; Dholpuria, S; Gupta, G; Dureja, H; Chellappan, DK; Singh, SK; Dua, K; Jha, SK
2021-03-09Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infectionSingh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G